Diferencia entre revisiones de «Ketamine»
Sin resumen de edición |
Sin resumen de edición |
||
| Línea 1: | Línea 1: | ||
==Contraindications== | == Contraindications == | ||
===Absolute=== | |||
# | === Absolute === | ||
#<3 mo old | |||
#Known or suspected schizophrenia, even if currently stable or controlled w/ meds | #Known or suspected schizophrenia, even if currently stable or controlled w/ meds | ||
===Relative=== | === Relative === | ||
#Major procedures involving posterior pharynx (e.g. endoscopy) | |||
##Typical minor ED oropharyngeal procedures are okay | #Major procedures involving posterior pharynx (e.g. endoscopy) | ||
#Airway instability (e.g. tracheal stenosis, tracheal surgery) | ##Typical minor ED oropharyngeal procedures are okay | ||
#Active pulmonary infection, including URI or asthma (unless for induction) | #Airway instability (e.g. tracheal stenosis, tracheal surgery) | ||
#CAD, HTN, CHF | #Active pulmonary infection, including URI or asthma (unless for induction) | ||
#CNS masses, hydrocephalus (head trauma okay) | #CAD, HTN, CHF | ||
#Glaucoma/acute globe injury | #CNS masses, hydrocephalus (head trauma okay) | ||
#Glaucoma/acute globe injury | |||
#Thyroid disorder or on thyroid medication | #Thyroid disorder or on thyroid medication | ||
==Preparation== | == Preparation == | ||
#Monitor | |||
#BVM (ready) | #Monitor | ||
#Suction | #BVM (ready) | ||
#Atropine | #Suction | ||
##Only recommended for pts w/ impaired ability to mobilize secretions | #Atropine | ||
##0.01 mg/kg IVP; min 0.1mg, max 0.5mg | ##Only recommended for pts w/ impaired ability to mobilize secretions | ||
#Versed | ##0.01 mg/kg IVP; min 0.1mg, max 0.5mg | ||
##Pretreatment is nonmandatory in both adults and children | #Versed | ||
##Consider 0.03mg/kg IVP if pt has unpleasant recovery reaction | ##Pretreatment is nonmandatory in both adults and children | ||
##Consider 0.03mg/kg IVP if pt has unpleasant recovery reaction | |||
#"Happy Place" | #"Happy Place" | ||
==Administration== | == Administration == | ||
#Give initial bolus | |||
##IV prefered over IM (faster recovery, less emesis) | #Give initial bolus | ||
##IV | ##IV prefered over IM (faster recovery, less emesis) | ||
###Children: 1.5-2 mg/kg (over 30-60sec) | ##IV | ||
###Adults: 1 mg/kg (over 30-60sec) | ###Children: 1.5-2 mg/kg (over 30-60sec) | ||
###Repeat dose 0.5-1 mg/kg q5-15 PRN | ###Adults: 1 mg/kg (over 30-60sec) | ||
##IM | ###Repeat dose 0.5-1 mg/kg q5-15 PRN | ||
###Children: 4-5 mg/kg | ##IM | ||
###Adult: 4-5 mg/kg | ###Children: 4-5 mg/kg | ||
###Repeat dose 2-4 mg/kg if sedation inadequate 10min after initial dose | ###Adult: 4-5 mg/kg | ||
###Repeat dose 2-4 mg/kg if sedation inadequate 10min after initial dose | |||
#Nystagmus = effect | #Nystagmus = effect | ||
==Side Effects== | == Side Effects == | ||
#Airway misalignment requiring repositioning of head (occasional) | |||
#Laryngospasm (0.3%) | #Airway misalignment requiring repositioning of head (occasional) | ||
##Only associated with unusually high IV doses | #Laryngospasm (0.3%) | ||
##Tx = BVM ventilation; intubation is rarely needed | ##Only associated with unusually high IV doses | ||
#Apnea or respiratory depression (0.8%) | ##Tx = BVM ventilation; intubation is rarely needed | ||
##Associated with rapid IV push | #Apnea or respiratory depression (0.8%) | ||
##Transient | ##Associated with rapid IV push | ||
#Hypersalivation (rare) | ##Transient | ||
#Emesis, usually well into recovery (8.4%) | #Hypersalivation (rare) | ||
#Recovery agitation (mild in 6.3%, clinically important in 1.4%) | #Emesis, usually well into recovery (8.4%) | ||
#Muscular hypertonicity and random, purposeless movements (common) | #Recovery agitation (mild in 6.3%, clinically important in 1.4%) | ||
#Muscular hypertonicity and random, purposeless movements (common) | |||
#Clonus, hiccupping, or short-lived nonallergic rash of face and neck | #Clonus, hiccupping, or short-lived nonallergic rash of face and neck | ||
==Discharge Criteria== | == Discharge Criteria == | ||
#Return to pretreatment level of verbalization/awareness | |||
#Return to pretreatment level of purposeful neuromuscular activity | #Return to pretreatment level of verbalization/awareness | ||
#Return to pretreatment level of purposeful neuromuscular activity | |||
#Do NOT have to wait until the pt can ambulate or tolerate PO | #Do NOT have to wait until the pt can ambulate or tolerate PO | ||
==Discharge Instructions== | == Intracranial pressure elevation == | ||
#NPO for 2hr | |||
== Discharge Instructions == | |||
#NPO for 2hr | |||
#No independent ambulation for 2hr | #No independent ambulation for 2hr | ||
==Source== | == See Also == | ||
Annals of EM. Clinical Practice Guideline for ED Ketamine Dissociative Sedation: 2011 Update | |||
[[Procedural Sedation]] | |||
== Source == | |||
Annals of EM. Clinical Practice Guideline for ED Ketamine Dissociative Sedation: 2011 Update | |||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revisión del 14:07 17 jul 2013
Contraindications
Absolute
- <3 mo old
- Known or suspected schizophrenia, even if currently stable or controlled w/ meds
Relative
- Major procedures involving posterior pharynx (e.g. endoscopy)
- Typical minor ED oropharyngeal procedures are okay
- Airway instability (e.g. tracheal stenosis, tracheal surgery)
- Active pulmonary infection, including URI or asthma (unless for induction)
- CAD, HTN, CHF
- CNS masses, hydrocephalus (head trauma okay)
- Glaucoma/acute globe injury
- Thyroid disorder or on thyroid medication
Preparation
- Monitor
- BVM (ready)
- Suction
- Atropine
- Only recommended for pts w/ impaired ability to mobilize secretions
- 0.01 mg/kg IVP; min 0.1mg, max 0.5mg
- Versed
- Pretreatment is nonmandatory in both adults and children
- Consider 0.03mg/kg IVP if pt has unpleasant recovery reaction
- "Happy Place"
Administration
- Give initial bolus
- IV prefered over IM (faster recovery, less emesis)
- IV
- Children: 1.5-2 mg/kg (over 30-60sec)
- Adults: 1 mg/kg (over 30-60sec)
- Repeat dose 0.5-1 mg/kg q5-15 PRN
- IM
- Children: 4-5 mg/kg
- Adult: 4-5 mg/kg
- Repeat dose 2-4 mg/kg if sedation inadequate 10min after initial dose
- Nystagmus = effect
Side Effects
- Airway misalignment requiring repositioning of head (occasional)
- Laryngospasm (0.3%)
- Only associated with unusually high IV doses
- Tx = BVM ventilation; intubation is rarely needed
- Apnea or respiratory depression (0.8%)
- Associated with rapid IV push
- Transient
- Hypersalivation (rare)
- Emesis, usually well into recovery (8.4%)
- Recovery agitation (mild in 6.3%, clinically important in 1.4%)
- Muscular hypertonicity and random, purposeless movements (common)
- Clonus, hiccupping, or short-lived nonallergic rash of face and neck
Discharge Criteria
- Return to pretreatment level of verbalization/awareness
- Return to pretreatment level of purposeful neuromuscular activity
- Do NOT have to wait until the pt can ambulate or tolerate PO
Intracranial pressure elevation
Discharge Instructions
- NPO for 2hr
- No independent ambulation for 2hr
See Also
Source
Annals of EM. Clinical Practice Guideline for ED Ketamine Dissociative Sedation: 2011 Update
